YS

YS Biopharma Co., Ltd. YS

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode YS VACC TCRT LENZ THRX SPPI ZVRA CRGX PRDS SLRN
6M 80.53 % 103.25 % -24.11 % -44.59 % 38.74 % 31.75 % -5.22 % 17.63 % 80.17 % -27.94 %
YTD 99.92 % 108.33 % 72.59 % -40.30 % 1.63 % 167.97 % -2.63 % -70.30 % 20.44 % -31.21 %
1Y -32.89 % 117.39 % 74.36 % -46.04 % -47.95 % -10.87 % -0.58 % -81.53 % 9.55 % -42.96 %
3Y -89.24 % -64.54 % -96.14 % 26.52 % -78.12 % -75.65 % 98.83 % -69.24 % -79.80 % -87.39 %
5Y -89.24 % -64.54 % -99.22 % -80.71 % -78.12 % -95.47 % -46.53 % -69.24 % -79.80 % -87.39 %
10Y -89.24 % -64.54 % -99.73 % -80.71 % -78.12 % -86.62 % -97.14 % -69.24 % -79.80 % -87.39 %
From the beginning -89.24 % -64.54 % -99.86 % -80.71 % -78.12 % -99.25 % -95.24 % -69.24 % -79.80 % -87.39 %

Dividend

LENZ Therapeutics, Inc.

Theseus Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.